Human Papillomavirus (HPV) affordability analysis
Client
MMGH supported the WHO Department of Immunisation and Biologicals (IVB) in defining a logical framework to assess the barriers to access human papillomavirus (HPV) vaccine in middle-income countries, with a focus on affordability. The project, performed in collaboration with the Clinton Health Access Initiative (CHAI), led to the identification of a subset of countries that can benefit from specific technical assistance related to affordability and access.
![](https://www.mmglobalhealth.org/wp-content/uploads/Human-Papillomavirus-HPV-affordability-analysis-1536x1024.jpg)
Focus Area
Policy & Strategy